0QLQ fundamentals
An in-depth look to YPSOMED HOLDING AG CHF14.15 (REGD) operating, investing, and financing activities
0QLQ free cash flow for H2 23 is 23.53 M CHF. For 2023, 0QLQ free cash flow was 46.85 M CHF and operating cash flow was 163.22 M CHF.
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: CHF
TTM